BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3361537)

  • 1. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease.
    Barnett AJ; Miller MH; Littlejohn GO
    J Rheumatol; 1988 Feb; 15(2):276-83. PubMed ID: 3361537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploratory clinical subgroup clustering in systemic sclerosis: Results from the Indian Progressive Systemic Sclerosis Registry.
    Philip SS; Janardana R; Shenoy P; Kavadichanda C; Bairwa D; Sircar G; Ghosh P; Wakhlu A; Selvam S; Khanna D; Shobha V
    J Scleroderma Relat Disord; 2024 Feb; 9(1):29-37. PubMed ID: 38333526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of Australian rheumatologists' perspectives of nutrition needs in systemic sclerosis.
    Samm DA; Macoustra AR; Crane RK; McWilliams LM; Proudman SM; Chapple LS
    J Scleroderma Relat Disord; 2023 Oct; 8(3):203-209. PubMed ID: 37744049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A data-driven approach finds RNA polymerase III antibody and tendon friction rubs as enrichment tools for early diffuse scleroderma trials.
    Domsic RT; Medsger TA; Gao S; Laffoon M; Huang S; Wisniewski S; Spino C; Steen V; Lafyatis R; Khanna D
    Rheumatology (Oxford); 2023 Apr; 62(4):1543-1551. PubMed ID: 36031807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis.
    Lazzaroni MG; Piantoni S; Angeli F; Bertocchi S; Franceschini F; Airò P
    Clin Rev Allergy Immunol; 2023 Jun; 64(3):358-377. PubMed ID: 35254622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS).
    Pettersson H; Alexanderson H; Poole JL; Varga J; Regardt M; Russell AM; Salam Y; Jensen K; Mansour J; Frech T; Feghali-Bostwick C; Varjú C; Baldwin N; Heenan M; Fligelstone K; Holmner M; Lammi MR; Scholand MB; Shapiro L; Volkmann ER; Saketkoo LA
    Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101695. PubMed ID: 34217607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis Subsets.
    Nevskaya T; Pope JE; Turk MA; Shu J; Marquardt A; van den Hoogen F; Khanna D; Fransen J; Matucci-Cerinic M; Baron M; Denton CP; Johnson SR
    J Rheumatol; 2021 Nov; 48(11):1698-1717. PubMed ID: 33993109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design.
    Domsic RT; Gao S; Laffoon M; Wisniewski S; Zhang Y; Steen V; Lafyatis R; Medsger TA
    Rheumatology (Oxford); 2021 Oct; 60(10):4662-4670. PubMed ID: 33506859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020 - Part 2.
    Knobler R; Arenberger P; Arun A; Assaf C; Bagot M; Berlin G; Bohbot A; Calzavara-Pinton P; Child F; Cho A; French LE; Gennery AR; Gniadecki R; Gollnick HPM; Guenova E; Jaksch P; Jantschitsch C; Klemke C; Ludvigsson J; Papadavid E; Scarisbrick J; Schwarz T; Stadler R; Wolf P; Zic J; Zouboulis C; Zuckermann A; Greinix H
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):27-49. PubMed ID: 32964529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic sclerosis-clinical picture, diagnosis, and treatment].
    Becker MO; Distler O; Maurer B
    Hautarzt; 2019 Sep; 70(9):723-741. PubMed ID: 31384958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic sclerosis-clinical picture, diagnosis, and treatment].
    Becker MO; Distler O; Maurer B
    Z Rheumatol; 2019 Jun; 78(5):439-457. PubMed ID: 31089800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of inpatient mortality in patients with systemic sclerosis: a case control study.
    Sehra ST; Kelly A; Baker JF; Derk CT
    Clin Rheumatol; 2016 Jun; 35(6):1631-5. PubMed ID: 27056049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Scleroderma: Bringing a Disease From Black-and-White Into Technicolor.
    Ligon CB; Wigley FM
    Arthritis Rheumatol; 2015 Dec; 67(12):3101-3. PubMed ID: 26245737
    [No Abstract]   [Full Text] [Related]  

  • 14. Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosis.
    Domsic RT; Nihtyanova SI; Wisniewski SR; Fine MJ; Lucas M; Kwoh CK; Denton CP; Medsger TA
    Arthritis Rheumatol; 2014 Jun; 66(6):1616-24. PubMed ID: 24470430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines on the use of extracorporeal photopheresis.
    Knobler R; Berlin G; Calzavara-Pinton P; Greinix H; Jaksch P; Laroche L; Ludvigsson J; Quaglino P; Reinisch W; Scarisbrick J; Schwarz T; Wolf P; Arenberger P; Assaf C; Bagot M; Barr M; Bohbot A; Bruckner-Tuderman L; Dreno B; Enk A; French L; Gniadecki R; Gollnick H; Hertl M; Jantschitsch C; Jung A; Just U; Klemke CD; Lippert U; Luger T; Papadavid E; Pehamberger H; Ranki A; Stadler R; Sterry W; Wolf IH; Worm M; Zic J; Zouboulis CC; Hillen U
    J Eur Acad Dermatol Venereol; 2014 Jan; 28 Suppl 1(Suppl 1):1-37. PubMed ID: 24354653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The road to early diagnosis of systemic sclerosis : the evolution of diagnostic and classification criteria in the past decades].
    Frerix M; Meier FM; Müller-Ladner U
    Z Rheumatol; 2013 Dec; 72(10):954-9. PubMed ID: 24337197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis.
    Cottrell TR; Wise RA; Wigley FM; Boin F
    Ann Rheum Dis; 2014 Jun; 73(6):1060-6. PubMed ID: 23606705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of T-cell subpopulations to superantigen and recall antigen stimulation in systemic sclerosis.
    Dar SA; Bhattacharya SN; Das S; Ramachandran VG; Banerjee BD; Arora P
    Indian J Dermatol; 2012 May; 57(3):175-80. PubMed ID: 22707766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies.
    Pendergrass SA; Lemaire R; Francis IP; Mahoney JM; Lafyatis R; Whitfield ML
    J Invest Dermatol; 2012 May; 132(5):1363-73. PubMed ID: 22318389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capturing the heterogeneity in systemic sclerosis with genome-wide expression profiling.
    Sargent JL; Whitfield ML
    Expert Rev Clin Immunol; 2011 Jul; 7(4):463-73. PubMed ID: 21790289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.